Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protein-rich fluid resuscitation versus crystalloids in human endotoxemia
NL-OMON52233Phase 2Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of octaplas lg, plasma-lyte and lipopolysaccharide endotoxin in sepsis (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Soluble syndecan-1 levels. Started May 2023; status: recruiting.
02
Drugs
octaplas lgplasma-lytelipopolysaccharide endotoxin
03
Conditions
sepsis
Beyond the preview
Go deeper on NL-OMON52233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52233.